Hematological Malignancies – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Hematologic malignancies, also known as hematological or blood cancers, refer to a group of cancers affecting the blood, bone marrow, and lymphatic system. These malignancies arise from abnormal growth and division of blood cells, including white, red, and platelets. Common hematologic malignancies include leukemia, lymphoma, and multiple myeloma. The signs and symptoms of hematologic malignancies can vary depending on the specific type and stage of the cancer. While the exact causes of hematologic malignancies are often unknown, several risk factors have been identified: Genetic predisposition, Exposure to certain chemicals and radiation, Age, Previous cancer treatments, and Viral infections. Hematologic malignancies arise from genetic mutations or abnormalities in the DNA of blood cells. These mutations disrupt the normal regulation of cell growth and division, leading to the uncontrolled proliferation of abnormal cells. Different blood cell lineages may be affected depending on...